Huashan Hospital, formerly the Chinese Red Cross General Hospital, is a teaching hospital in Shanghai, China, affiliated with the Shanghai Medical College of Fudan University.

There are 1,216 (main branch) beds in Huashan Hospital.

During the past decade, Huashan Hospital conducted 68 clinical trials. In the 10-year time frame, 68 clinical trials started and 3 clinical trials were completed, i.e. on average, 4.4% percent of trials that started reached the finish line to date. In the past 5 years, 40 clinical trials started and 2 clinical trials were completed. i.e. 5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Huashan Hospital" #1 sponsor was "Huashan Hospital" with 39 trials, followed by "Fudan University" with 9 trials sponsored, "Shanghai Tongji Hospital, Tongji University School of Medicine" with 6 trials sponsored, "Xiamen Amoytop Biotech Co., Ltd." with 5 trials sponsored and "Beijing Friendship Hospital" with 5 trials sponsored. Other sponsors include 34 different institutions and companies that sponsored additional 41 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Huashan Hospital" #1 collaborator was "Huashan Hospital" with 13 trials as a collaborator, "Peking Union Medical College Hospital" with 5 trials as a collaborator, "Changhai Hospital" with 3 trials as a collaborator, "Chinese PLA General Hospital" with 3 trials as a collaborator and "Ningbo No. 1 Hospital" with 3 trials as a collaborator. Other collaborators include 213 different institutions and companies that were collaborators in the rest 189 trials.

According to Clinical.Site data, the most researched conditions in "Huashan Hospital" are "Hepatocellular Carcinoma" (4 trials), "Obesity" (4 trials), "Stroke" (4 trials), "Parkinson Disease" (3 trials) and "Acne Vulgaris" (2 trials). Many other conditions were trialed in "Huashan Hospital" in a lesser frequency.

Most popular intervention types in "Huashan Hospital" are "Drug" (51 trials), "Other" (18 trials), "Device" (11 trials), "Procedure" (8 trials) and "Diagnostic Test" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Ypeginterferon alfa-2b" (4 trials), "not intervention" (3 trials), "ALA 10%" (2 trials) and "ALA 5%" (2 trials). Other intervention names were less common.

The vast majority of trials in "Huashan Hospital" are 99 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are 32 active trials in "Huashan Hospital". 2 are not yet recruiting, 25 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 40 completed trials in Huashan Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Huashan Hospital, 8 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 20 trials that are defined as “Not Applicable".